Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas.

Department of Neurology, University Medical Center Utrecht, The Netherlands.
Neurology (Impact Factor: 8.3). 04/2001; 56(5):618-23. DOI: 10.1212/WNL.56.5.618
Source: PubMed

ABSTRACT The preferred management of patients with suspected low-grade gliomas (S-LGG) remains controversial. The benefits of resection or radiotherapy early in the course of the disease have not been proven in terms of survival. Little is known about the effects of early therapy on quality of life (QOL) and cognitive status. The authors compared functional status, QOL, and cognitive status of patients suspected of having a LGG, in whom treatment was deferred, and patients with proven LGG (P-LGG), who underwent early surgery.
The authors recruited 24 patients suspected of having an LGG. These patients were matched with 24 patients with a histologically proven LGG and healthy control subjects for educational level, handedness, age, and gender. The two patient groups were also matched for tumor laterality, use of anticonvulsants, and interval between diagnosis and testing. Functional status was determined in both patient groups. QOL and cognitive status were compared between the three groups.
Matching criteria and functional status did not differ significantly between groups. Both patient groups scored worse on QOL scales than healthy control subjects. Unoperated patients with S-LGG scored better on most items than patients with P-LGG. Cognitive status was worse in both groups than in healthy control subjects, but, again, patients with S-LGG performed better than patients with P-LGG.
These data suggest that a wait-and-see policy in patients with S-LGG has no negative effect on cognitive performance and QOL.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Resumen. El presente estudio pretende definir el papel del tumor en el rendimiento neurop-sicológico de pacientes con sospecha radiológica de glioma, siendo la valoración en el momento inicial de la enfermedad, previo a la resección quirúrgica. La muestra incluyó 29 pacientes (18 hombres y 11 mujeres) con una edad media de 54 años. A todos ellos se les ha aplicado una batería neuropsicológica para valorar atención, memoria, habilidades viso-constructivas, organización visual, lenguaje y funciones ejecutivas. Los resultados arrojan que más del 50% de la muestra, presenta puntuaciones centiles por debajo de 40 o por deba-jo del punto de corte establecido, para todas las variables, excepto en orientación y recuer-do verbal a corto plazo. El grupo de pacientes con gliomas de bajo grado presenta un mejor rendimiento en habilidades de planificación y seguimiento de una estrategia determinada, con respecto a los pacientes con glioma de alto grado. No se observan diferencias en el ren-dimiento neuropsicológico en relación al hemisferio afectado. Además, dado que la edad es una variable que influye en el rendimiento neuropsicológico, se identifico que ésta era la encargada de explicar las diferencias entre pacientes con glioma de alto y bajo grado, no siendo así en cuanto al hemisferio afectado. Palabras clave: glioma, valoración neuropsicológica, déficit neuropsicológico. Abstract. The aim of this study was to define the role of a glioma in neuropsychological performance, in the initial stage of the disease. Materials and Method: The sample included 29 patients with radiological suspected glioma who were undergoing surgical resection (18 men and 11 women) with a mean age of 54. All subjects were administered a neuropsycho-logical battery assessing attention, memory, language, visuoconstructive skills, visual organization, language and executive functions. The results show that over 50% of the sam-ple presented scores below the 40 percentile or below the cut-off for all variables, except for orientation and short-term verbal memory. In addition, patients with low grade gliomas showed better performance in planning and monitoring skills of a particular strategy, with respect to patients with light grade glioma. There were no differences in neuropsychologi-cal performance in relation to the hemisphere affected by the tumor. Mainly, the age is the variable responsible for explaining differences in cognitive performance of patients studied.
  • [Show abstract] [Hide abstract]
    ABSTRACT: LGGs (low-grade gliomas) are sometimes encountered by chance during radiological examinations. These incidentally discovered LGGs (IDLGGs) were relatively under-studied in the literature. The purpose of current study is to review a cohort of patients with IDLGGs surgically treated in our institution for their clinical and histological aspects and determine their IDH1 and 1p19q status. All patients with hemispheric LGGs receiving operation in our institution between 2001 and 2004 were reviewed. Clinical, radiological and treatment data of the patients were collected and IDLGGs were retrieved and compared with symptomatic LGGs. Histological review was carried out and formalin-fixed paraffin embedded (FFPE) tissues of IDLGGs were examined for IDH1/IDH2 mutation and 1p/19q codeletion. Twenty three IDLGGs (10.4%) were identified while 196 patients had symptomatic LGGs. The reasons for patients with IDLGGs having radiological examination included trauma (47.8%), dizziness (26.1%), unrelated headache (21.7%), and health checkup (4.4%). Clinically, patients with IDLGGs had higher preoperative KPS (P < 0.001), smaller tumor volume (P = 0.014), lower frequency of eloquent areas involvement (P < 0.001) and higher rate of complete resection (P = 0.037) comparing to those with symptomatic LGGs. Histologically, there is a preponderance of oligodendroglial differentiation with 6 oligodendrogliomas and 11 oligoastrocytomas but there were also 6 astrocytomas. IDH1 mutation and 1p/19q co-deletion were detected in 95.7% (22/23) and 69.6% (16/23) of IDLGGs, respectively. The latter encompassed all but one of the cases of oligodendroglial tumors. Patients with IDLGGs had longer overall survival than those with symptomatic LGGs (P = 0.027). We conclude that the majority of IDLGGs are IDH1 mutated and are predominantly oligodendroglial tumors. With a median follow-up of 9.3 years to our series, we conclude that patients with IDLGGs had better prognosis than those with symptomatic LGGs. The favorable prognosis of IDLGGs may be accounted by the higher practicability of extensive resection, non-eloquent tumor location and smaller tumor volume. Frequent IDH1 mutation and 1p/19q co-deletion in IDLGGs may also contribute to the favorable prognosis of this subgroup of patients.
    International journal of clinical and experimental pathology 01/2014; 7(12):8627-36. · 1.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The preferred management of suspected low-grade gliomas (LGGs) has been disputed, and the implications of molecular changes for medical and surgical management of LGGs are important to consider. Current strategies that make use of molecular markers and imaging techniques and therapeutic considerations offer additional options for management of LGGs. Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes suggest a role for this abnormal metabolic pathway in the pathogenesis and progression of these primary brain tumors. Use of magnetic resonance spectroscopy can provide preoperative detection of IDH-mutated gliomas and affect surgical planning. In addition, IDH1 and IDH2 mutation status may have an effect on surgical resectability of gliomas. The IDH-mutated tumors exhibit better prognosis throughout every grade of glioma, and mutation may be an early genetic event, preceding lineage-specific secondary and tertiary alterations that transform LGGs into secondary glioblastomas. The O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation and 1p19q codeletion status can predict sensitivity to chemotherapy and radiation in low- and intermediate-grade gliomas. Thus, these recent advances, which have led to a better understanding of how molecular, genetic, and epigenetic alterations influence the pathogenicity of the different histological grades of gliomas, can lead to better prognostication and may lead to specific targeted surgical interventions and medical therapies.
    Neurosurgical FOCUS 03/2015; 38(3):E2. DOI:10.3171/2015.1.FOCUS14745 · 2.14 Impact Factor

Full-text (2 Sources)

Available from
Jun 3, 2014